TABLE 3.
Reference | Location | Study participants, no. | Age at study | Time of year | Prevalence, % | Cutoff serum 25(OH)D, nmol/L |
Challaet al., 2005 (45) | Ioannina, Greece | 66 | 6 mo | All | 27 | <25 |
Bhalala et al., 2007 (44) | Mumbai, India | 35 | 3 mo | NS | 51 | <37.5 |
Seth et al., 2009 (46) | New Delhi, India | 180 | 2–24 wk | All | 43 | <25 |
Dawodu et al., 2003 (27) | Al Ain , United Arab Emirates | 78 | 1–4 mo | All | 82 | <25 |
Dawodu et al., 2010 (43) | Cincinnati, Ohio, United States | 87 | 1 mo | All | 18 76 | <25 <50 |
Wagner et al., 2010 (47) | Charleston, South Carolina, United States | 33 | 1 mo | All | 72 | <50 |
Divide values by 2.5 to convert to μg/L. 25(OH)D, 25-hydroxyvitamin D.